Article
Stem cell integrins: Implications for ex-vivo culture and cellular therapies
8 Oct 2010
Abstract excerpt
Use of stem cells, whether adult or embryonic for clinical applications to treat diseases such as Parkinson's, macular degeneration or Type I diabetes will require a homogenous population of mature, terminally differentiated cells. A current area of intense interest is the development of defined surfaces for stem cell derivation, maintenance, proliferation and subsequent differentiation, which are capable of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
